ConductScience.org, home

Library / Genes

TENM1: teneurin transmembrane protein 1

1 protein, 26 patents, 0 drugs, 0 trials, 4,525 NIH grants and 65,045 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolTENM1HGNC
Nameteneurin transmembrane protein 1HGNC
NCBI Gene ID10178NCBI Gene
HGNC IDHGNC:8117HGNC
EnsemblENSG00000009694NCBI Gene
AliasesODZ1, ODZ3, TEN-M1, TEN1, TNM, TNM1, ten-1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q9UKZ4Teneurin-12,7250Ensembl, GeneID, HGNCUniProt

Patents 26

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4641201 A22025-10-299135Q9UKZ4Espacenet
EP 4641202 A22025-10-29508Q9UKZ4Espacenet
JP 2025138725 A2025-09-252418Q9UKZ4Espacenet
JP 2025529142 A2025-09-044640Q9UKZ4Espacenet
US 12371689 B22025-07-294640Q9UKZ4Espacenet
JP 2025517969 A2025-06-129135Q9UKZ4Espacenet
KR 1020250017231 A2025-02-04508Q9UKZ4Espacenet
JP 2023145599 A2023-10-112418Q9UKZ4Espacenet
US 11446398 B22022-09-2087635Q9UKZ4Espacenet
US 11400116 B22022-08-023896Q9UKZ4Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4525

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant3532,025NIH's project files
P30CA016672Cancer Center Support Grant2332,025NIH's project files
P30CA006973Regional Oncology Research Center612,025NIH's project files
P30CA016058Cancer Center Support Grant402,025NIH's project files
T32CA082088T32 Urologic Oncology Research Training Grant382,025NIH's project files
P30CA006927Comprehensive Cancer Center Program at Fox Chase372,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant332,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award312,025NIH's project files
P30CA086862Cancer Center Support Grant292,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant242,025NIH's project files

Papers 65045

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42824896PubTator, text miningPubMed
42823561PubTator, text miningPubMed
42821034PubTator, text miningPubMed
42816638PubTator, text miningPubMed
42813396PubTator, text miningPubMed
42812728PubTator, text miningPubMed
42811535PubTator, text miningPubMed
42798335PubTator, text miningPubMed
42795990PubTator, text miningPubMed
42788523PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license